{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:59:14Z","timestamp":1791939554181,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The chikungunya virus (CHIKV) has become a substantial global health threat due to its massive re-emergence, the considerable disease burden and the lack of vaccines or therapeutics. We discovered a novel class of small molecules ([1,2,3]triazolo[4,5-\n                    <jats:italic>d<\/jats:italic>\n                    ]pyrimidin-7(6\n                    <jats:italic>H<\/jats:italic>\n                    )-ones) with potent\n                    <jats:italic>in vitro<\/jats:italic>\n                    activity against CHIKV isolates from different geographical regions. Drug-resistant variants were selected and these carried a P34S substitution in non-structural protein 1 (nsP1), the main enzyme involved in alphavirus RNA capping. Biochemical assays using nsP1 of the related Venezuelan equine encephalitis virus revealed that the compounds specifically inhibit the guanylylation of nsP1. This is, to the best of our knowledge, the first report demonstrating that the alphavirus capping machinery is an excellent antiviral drug target. Considering the lack of options to treat CHIKV infections, this series of compounds with their unique (alphavirus-specific) target offers promise for the development of therapy for CHIKV infections.\n                  <\/jats:p>","DOI":"10.1038\/srep31819","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T05:42:15Z","timestamp":1471844535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection"],"prefix":"10.1038","volume":"6","author":[{"given":"L.","family":"Delang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Qu\u00e9rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. C.","family":"Albulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"De Burghgraeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A. Segura","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Piorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Canard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"P\u00e9rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"van Hemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Coutard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Leyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"BFsrep31819_CR1","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","volume":"75","author":"AM Powers","year":"2001","unstructured":"Powers, A. M. et al. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 75, 10118\u201310131 (2001).","journal-title":"J. Virol."},{"key":"BFsrep31819_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/QCO.0b013e328356ffd5","volume":"25","author":"LH Chen","year":"2012","unstructured":"Chen, L. H. & Wilson, M. E. Dengue and chikungunya in travelers. Current Opinion in Infectious Diseases 25, 523\u2013529 (2012).","journal-title":"Current Opinion in Infectious Diseases"},{"key":"BFsrep31819_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1476-072X-8-61","volume":"8","author":"N Tilston","year":"2009","unstructured":"Tilston, N., Skelly, C. & Weinstein, P. Pan-European Chikungunya surveillance: designing risk stratified surveillance zones. Int. J. Health Geogr. 8, 61 (2009).","journal-title":"Int. J. Health Geogr."},{"key":"BFsrep31819_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(14)60185-9","volume":"383","author":"I Leparc-Goffart","year":"2014","unstructured":"Leparc-Goffart, I., Nougairede, A., Cassadou, S., Prat, C. & De Lamballerie, X. Chikungunya in the Americas. The Lancet 383, 514 (2014).","journal-title":"The Lancet"},{"key":"BFsrep31819_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcv.2015.05.021","volume":"69","author":"JMDLa Hoz","year":"2015","unstructured":"Hoz, J. M. D. La et al. Fatal cases of Chikungunya virus infection in Colombia: Diagnostic and treatment challenges. J. Clin. Virol. 69, 27\u201329 (2015).","journal-title":"J. Clin. Virol."},{"key":"BFsrep31819_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.idcr.2014.12.002","volume":"2","author":"JR Torres","year":"2015","unstructured":"Torres, J. R. et al. Chikungunya fever: Atypical and lethal cases in the Western hemisphere. IDCases 2, 6\u201310 (2015).","journal-title":"IDCases"},{"key":"BFsrep31819_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/rmv.681","volume":"21","author":"SK Singh","year":"2011","unstructured":"Singh, S. K. & Unni, S. K. Chikungunya virus: Host pathogen interaction. Rev. Med. Virol. 21, 78\u201388 (2011).","journal-title":"Rev. Med. Virol."},{"key":"BFsrep31819_CR8","doi-asserted-by":"publisher","first-page":"e2137","DOI":"10.1371\/journal.pntd.0002137","volume":"7","author":"C Schilte","year":"2013","unstructured":"Schilte, C. et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl. Trop. Dis. 7, e2137 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFsrep31819_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jmv.21663","volume":"82","author":"M Khan","year":"2010","unstructured":"Khan, M., Santhosh, S. R., Tiwari, M., Lakshmana Rao, P. V. & Parida, M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in Vero cells. J. Med. Virol. 82, 817\u2013824 (2010).","journal-title":"J. Med. Virol."},{"key":"BFsrep31819_CR10","first-page":"217","volume":"66","author":"SW Brighton","year":"1984","unstructured":"Brighton, S. W. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. South African Med. J. 66, 217\u2013218 (1984).","journal-title":"South African Med. J."},{"key":"BFsrep31819_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/vbz.2008.0049","volume":"8","author":"X De Lamballerie","year":"2008","unstructured":"De Lamballerie, X. et al. On chikungunya acute infection and chloroquine treatment. Vector borne zoonotic Dis. 8, 837\u2013839 (2008).","journal-title":"Vector borne zoonotic Dis."},{"key":"BFsrep31819_CR12","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dku209","volume":"69","author":"L Delang","year":"2014","unstructured":"Delang, L. et al. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J. Antimicrob. Chemother. 69, 2770\u20132784 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFsrep31819_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","volume":"121","author":"R Abdelnabi","year":"2015","unstructured":"Abdelnabi, R., Neyts, J. & Delang, L. Towards antivirals against the chikungunya virus. Antiviral Res. 121, 59\u201368 (2015).","journal-title":"Antiviral Res."},{"key":"BFsrep31819_CR14","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1021\/jm401844c","volume":"57","author":"A Gigante","year":"2014","unstructured":"Gigante, A. et al. Identification of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as novel inhibitors of Chikungunya virus replication. J. Med. Chem. 57, 4000\u20134008 (2014).","journal-title":"J. Med. Chem."},{"key":"BFsrep31819_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2009.07.013","volume":"393","author":"B Salvador","year":"2009","unstructured":"Salvador, B., Zhou, Y., Michault, A., Muench, M. O. & Simmons, G. Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 393, 33\u201341 (2009).","journal-title":"Virology"},{"key":"BFsrep31819_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","volume":"90","author":"I Delogu","year":"2011","unstructured":"Delogu, I. et al. In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antiviral Res. 90, 99\u2013107 (2011).","journal-title":"Antiviral Res."},{"key":"BFsrep31819_CR17","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1099\/vir.0.069690-0","volume":"95","author":"IC Albulescu","year":"2014","unstructured":"Albulescu, I. C., Tas, A., Scholte, F. E. M., Snijder, E. J. & van Hemert, M. J. An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors. J. Gen. Virol. 95, 2683\u20132692 (2014).","journal-title":"J. Gen. Virol."},{"key":"BFsrep31819_CR18","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1128\/JVI.00599-15","volume":"89","author":"C Li","year":"2015","unstructured":"Li, C. et al. mRNA capping by Venezuelan Equine Encephalitis Virus nsP1: Functional characterization and implication for antiviral research. J. Virol. 89, 8292\u20138303 (2015).","journal-title":"J. Virol."},{"key":"BFsrep31819_CR19","doi-asserted-by":"publisher","first-page":"e71047","DOI":"10.1371\/journal.pone.0071047","volume":"8","author":"FEM Scholte","year":"2013","unstructured":"Scholte, F. E. M. et al. Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS One 8, e71047 (2013).","journal-title":"PLoS One"},{"key":"BFsrep31819_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrmicro2675","volume":"10","author":"E Decroly","year":"2012","unstructured":"Decroly, E., Ferron, F., Lescar, J. & Canard, B. Conventional and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol. 10, 51\u201365 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFsrep31819_CR21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/jvi.71.1.392-397.1997","volume":"71","author":"T Ahola","year":"1997","unstructured":"Ahola, T., Laakkonen, P., Vihinen, H. & K\u00e4\u00e4ri\u00e4inen, L. Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities. J. Virol. 71, 392\u2013397 (1997).","journal-title":"J. Virol."},{"key":"BFsrep31819_CR22","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.febslet.2012.05.024","volume":"586","author":"HY Lin","year":"2012","unstructured":"Lin, H. Y., Yu, C. Y., Hsu, Y. H. & Meng, M. Functional analysis of the conserved histidine residue of Bamboo mosaic virus capping enzyme in the activity for the formation of the covalent enzyme-m7GMP intermediate. FEBS Lett. 586, 2326\u20132331 (2012).","journal-title":"FEBS Lett."},{"key":"BFsrep31819_CR23","doi-asserted-by":"publisher","first-page":"17281","DOI":"10.1074\/jbc.M910340199","volume":"275","author":"L Vasiljeva","year":"2000","unstructured":"Vasiljeva, L., Merits, A., Auvinen, P. & K\u00e4\u00e4ri\u00e4inen, L. Identification of a novel function of the Alphavirus capping apparatus. RNA 5\u2032-triphosphatase activity of Nsp2. J. Biol. Chem. 275, 17281\u201317287 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFsrep31819_CR24","doi-asserted-by":"publisher","first-page":"e22336","DOI":"10.1371\/journal.pone.0022336","volume":"6","author":"YA Karpe","year":"2011","unstructured":"Karpe, Y. A., Aher, P. P. & Lole, K. S. NTPase and 5\u2032-RNA triphosphatase activities of chikungunya virus nsP2 protein. PLoS One 6, e22336 (2011).","journal-title":"PLoS One"},{"key":"BFsrep31819_CR25","doi-asserted-by":"publisher","first-page":"e1002830","DOI":"10.1371\/journal.ppat.1002830","volume":"8","author":"RM DuBois","year":"2012","unstructured":"DuBois, R. M. et al. Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease. PLoS Pathog. 8, e1002830 (2012).","journal-title":"PLoS Pathog."},{"key":"BFsrep31819_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2012.07.007","volume":"96","author":"F Ferron","year":"2012","unstructured":"Ferron, F., Decroly, E., Selisko, B. & Canard, B. The viral RNA capping machinery as a target for antiviral drugs. Antiviral Res. 96, 21\u201331 (2012).","journal-title":"Antiviral Res."},{"key":"BFsrep31819_CR27","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1021\/jm00102a010","volume":"35","author":"J Balzarini","year":"1992","unstructured":"Balzarini, J., De Clercq, E., Serafinowski, P., Dorland, E. & Harrap, K. R. Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives. J. Med. Chem. 35, 4576\u20134583 (1992).","journal-title":"J. Med. Chem."},{"key":"BFsrep31819_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-015-0050-0","volume":"10","author":"T Ahola","year":"2015","unstructured":"Ahola, T. & Karlin, D. G. Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses. Biol. Direct 10, 1\u201321 (2015).","journal-title":"Biol. Direct"},{"key":"BFsrep31819_CR29","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1128\/JVI.00553-15","volume":"89","author":"KJ Sokoloski","year":"2015","unstructured":"Sokoloski, K. J. et al. Noncapped alphavirus genomic RNAs and their role during infection. J. Virol. 89, 6080\u20136092 (2015).","journal-title":"J. Virol."},{"key":"BFsrep31819_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3201\/eid1403.070906","volume":"14","author":"M Panning","year":"2008","unstructured":"Panning, M., Grywna, K., Van Esbroeck, M., Emmerich, P. & Drosten, C. Chikungunya fever in travelers returning to Europe from the Indian Ocean Region, 2006. Emerg. Infect. Dis. 14, 416\u2013422 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"BFsrep31819_CR31","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1099\/vir.0.2008\/002121-0","volume":"89","author":"LVan Tan","year":"2008","unstructured":"Tan, L. Van et al. Me Tri virus: A Semliki Forest virus strain from Vietnam? J. Gen. Virol. 89, 2132\u20132135 (2008).","journal-title":"J. Gen. Virol."},{"key":"BFsrep31819_CR32","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1074\/jbc.M509747200","volume":"281","author":"D Lavillette","year":"2006","unstructured":"Lavillette, D. et al. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J. Biol. Chem. 281, 3909\u20133917 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFsrep31819_CR33","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1128\/JVI.03612-14","volume":"89","author":"FEM Scholte","year":"2015","unstructured":"Scholte, F. E. M. et al. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J. Virol. 89, 4457\u20134469 (2015).","journal-title":"J. Virol."},{"key":"BFsrep31819_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/1743-422X-8-353","volume":"8","author":"SW Metz","year":"2011","unstructured":"Metz, S. W. et al. Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells. Virol. J. 8, 353 (2011).","journal-title":"Virol. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31819","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:13:58Z","timestamp":1672881238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,31]]}},"alternative-id":["BFsrep31819"],"URL":"https:\/\/doi.org\/10.1038\/srep31819","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726664420.793539884","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"assertion":[{"value":"16 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31819"}}